ArticleMolecules (Basel, Switzerland)2025

Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs.

Kevin Delgado-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.